Research paperVismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma
Under a Creative Commons license
open access
Keywords
Locally advanced basal cell carcinoma
Neoadjuvant
Vismodegib
Cited by (0)
2,3,4,5,6 and 9 are members of the CARADERM network.
- 1
These authors contributed equally to the work.
© 2021 The Author(s). Published by Elsevier Ltd.